Literature DB >> 12462335

Bone-specific antibodies in sera from patients with celiac disease: characterization and implications in osteoporosis.

Emilia Sugai1, Alejandra Cherñavsky, Silvia Pedreira, Edgardo Smecuol, Horacio Vazquez, Sonia Niveloni, Roberto Mazure, Eduardo Mauriro, Gabriel A Rabinovich, Julio C Bai.   

Abstract

Osteopenia and osteoporosis are well-known complications detected in celiac disease patients with still obscure pathogenesis. In the present study we investigated the presence of circulating anti-bone autoantibodies in patients with celiac disease and explored their role in the associated bone disease. We evaluated serum samples from 33 patients at the time of diagnosis and from 20 of them after treatment. Sera from patients with inflammatory bowel disease (n = 9), nonceliac osteoporotic (n = 18), and healthy individuals (n = 10) were used as controls. The presence of IgA specific anti-bone antibodies was first investigated using indirect immunofluorescence on cryosections of fetal rat tibia (20-day pregnancy). Furthermore, samples were homogenized and total tissue extracts were subjected to Western blot analysis to confirm immunoreactivity. At diagnosis, sera from 51.5% (17/33) of celiac patients had antibodies that recognized antigenic structures in chondrocytes and the extracellular matrix along mature cartilage, bone interface, and perichondrium of fetal rat bone. Among controls, only two osteoporotic patients showed very low titles of anti-bone autoantibodies. The immunostaining was localized in areas where an active mineralization process occurred and was similar to the distribution of the native bone tissue transglutaminase. The frequency of patients with positive baseline titers of anti-bone antibodies diminished significantly after treatment (P = 0.048). Western blot assays confirmed the presence of autoantibodies in sera from patients with a positive immunofluorescence staining. Autoantibodies recognized a major protein band on tissue extracts with a molecular weight of 77-80 kDa, which could be displaced when sera were preadsorbed with human recombinant tissue transglutaminase. We provide original evidence that patients with celiac disease have IgA-type circulating autoantibodies against intra- and extracellular structures of fetal rat tibia. Our findings suggest that these antibodies recognize bone tissue transglutaminase as the autoantigen, and based on the localization of the immunoreactivity we speculate that they might have an active role in the pathophysiology of celiac disease-associated bone complications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12462335     DOI: 10.1023/a:1020786315956

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  20 in total

1.  Osteopenia in patients with clinically silent coeliac disease warrants screening.

Authors:  K Mustalahti; P Collin; H Sievänen; J Salmi; M Mäki
Journal:  Lancet       Date:  1999-08-28       Impact factor: 79.321

2.  Risk of fractures in celiac disease patients: a cross-sectional, case-control study.

Authors:  H Vasquez; R Mazure; D Gonzalez; D Flores; S Pedreira; S Niveloni; E Smecuol; E Mauriño; J C Bai
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

3.  Analysis of interleukin-4 and interleukin-10 and their association with the lymphocytic infiltrate in the small intestine of patients with coeliac disease.

Authors:  C G Beckett; D Dell'Olio; M Kontakou; R T Przemioslo; S Rosen-Bronson; P J Ciclitira
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

4.  Identification of tissue transglutaminase as the autoantigen of celiac disease.

Authors:  W Dieterich; T Ehnis; M Bauer; P Donner; U Volta; E O Riecken; D Schuppan
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  Current concepts of celiac disease pathogenesis.

Authors:  D Schuppan
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

7.  Low circulating insulin-like growth factor I in coeliac disease and its relation to bone mineral density.

Authors:  T Valdimarsson; H J Arnqvist; G Toss; G Järnerot; F Nyström; M Ström
Journal:  Scand J Gastroenterol       Date:  1999-09       Impact factor: 2.423

8.  IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease.

Authors:  T P Chorzelski; E H Beutner; J Sulej; H Tchorzewska; S Jablonska; V Kumar; A Kapuscinska
Journal:  Br J Dermatol       Date:  1984-10       Impact factor: 9.302

9.  Body composition and bone mineral density in untreated and treated patients with celiac disease.

Authors:  D González; R Mazure; C Mautalen; H Vazquez; J Bai
Journal:  Bone       Date:  1995-02       Impact factor: 4.398

10.  Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes.

Authors:  D Aeschlimann; A Wetterwald; H Fleisch; M Paulsson
Journal:  J Cell Biol       Date:  1993-03       Impact factor: 10.539

View more
  17 in total

1.  What do Brazilian pediatricians know about celiac disease?

Authors:  Camilo Vieira; Marília Matos; Thaise Quaresma; Juliana de Oliveira; Cibele Dantas Ferreira; Adriza Silva; Daniel Diniz-Santos; Luciana R Silva
Journal:  Dig Dis Sci       Date:  2010-07-15       Impact factor: 3.199

Review 2.  Antibodies in celiac disease: implications beyond diagnostics.

Authors:  Sergio Caja; Markku Mäki; Katri Kaukinen; Katri Lindfors
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 3.  Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.

Authors:  Stefania Martucciello; Gaetana Paolella; Carla Esposito; Marilena Lepretti; Ivana Caputo
Journal:  Cell Mol Life Sci       Date:  2018-08-22       Impact factor: 9.261

Review 4.  Bone and Celiac Disease.

Authors:  María Belén Zanchetta; Vanesa Longobardi; Julio César Bai
Journal:  Curr Osteoporos Rep       Date:  2016-04       Impact factor: 5.096

5.  Abnormal Skeletal Strength and Microarchitecture in Women With Celiac Disease.

Authors:  Emily M Stein; Halley Rogers; Alexa Leib; Donald J McMahon; Polly Young; Kyle Nishiyama; X Edward Guo; Suzanne Lewis; Peter H Green; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2015-04-13       Impact factor: 5.958

Review 6.  Celiac Disease-Musculoskeletal Manifestations and Mechanisms in Children to Adults.

Authors:  Haley M Zylberberg; Benjamin Lebwohl; Peter H R Green
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

Review 7.  Chronic pediatric inflammatory diseases: effects on bone.

Authors:  Anuradha Viswanathan; Francisco A Sylvester
Journal:  Rev Endocr Metab Disord       Date:  2007-12-29       Impact factor: 6.514

Review 8.  Extraintestinal manifestations of coeliac disease.

Authors:  Daniel A Leffler; Peter H R Green; Alessio Fasano
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-08-11       Impact factor: 46.802

9.  Prevalence of IgA-antiendomysial antibody in a patient cohort with idiopathic low bone mineral density.

Authors:  T Karakan; O Ozyemisci-Taskiran; Z Gunendi; F Atalay; C Tuncer
Journal:  World J Gastroenterol       Date:  2007-06-07       Impact factor: 5.742

10.  Long-term fracture risk in patients with celiac disease: a population-based study in Olmsted County, Minnesota.

Authors:  Mohammed R Jafri; Charles W Nordstrom; Joseph A Murray; Carol T Van Dyke; Ross A Dierkhising; Alan R Zinsmeister; Lee J Melton
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.